Cresco Labs Inc. (CRLBF) Accumulated Expenses (2020 - 2026)

Cresco Labs (CRLBF) has reported Accumulated Expenses for 7 consecutive years, with $54.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Accumulated Expenses changed 0.45% year-over-year to $54.2 million; the trailing twelve-month figure through Jun 2026 stood at $54.2 million (changed 0.45% YoY), and the FY2025 full-year result was $58.0 million, up 6.85% from the prior year.
• Accumulated Expenses retreated to $54.2 million in Q2 2026 per CRLBF's latest filing, from $55.0 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $96.0 million in Q1 2022 and bottomed at $45.9 million in Q2 2022.
• Historically, Accumulated Expenses has averaged $62.5 million across 5 years, with a median of $58.3 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Accumulated Expenses tumbled 31.73% in 2022, then surged 69.88% in 2023.
• Over 5 years, Accumulated Expenses stood at $65.2 million in 2022, then gained by 6.01% to $69.1 million in 2023, then slipped by 21.4% to $54.3 million in 2024, then increased by 6.85% to $58.0 million in 2025, then slipped by 6.61% to $54.2 million in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $54.2 million, $55.0 million, and $58.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.